BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 14.02.1996

Briefing Document for Biological Response Modifiers Advisory Committee; Availability

The Food and Drug Administration (FDA) is announcing the availability of a draft document entitled ``Addendum to the Points to Consider on Human Somatic Cell and Gene Therapy (1991).'' This draft addendum is being made available as briefing material for the February 1996 Biological Response Modifiers Advisory Committee meeting. This action is being taken to ensure that all interested parties are aware of the information in the document that will be the subject of the committee's discussion.

Source: Federal Register — Food and Drug AdministrationOpen original release →